Načítá se...
HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells
A small number of HIV-1–infected individuals develop broadly neutralizing antibodies to the virus (bNAbs). These antibodies are protective against infection in animal models. However, they only emerge 1–3 yr after infection, and show a number of highly unusual features including exceedingly high lev...
Uloženo v:
| Vydáno v: | J Exp Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Rockefeller University Press
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6547862/ https://ncbi.nlm.nih.gov/pubmed/30975893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20190287 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|